138 related articles for article (PubMed ID: 8032286)
1. A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis.
Davis NL; Grieder FB; Smith JF; Greenwald GF; Valenski ML; Sellon DC; Charles PC; Johnston RE
Arch Virol Suppl; 1994; 9():99-109. PubMed ID: 8032286
[TBL] [Abstract][Full Text] [Related]
2. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus.
Aronson JF; Grieder FB; Davis NL; Charles PC; Knott T; Brown K; Johnston RE
Virology; 2000 Apr; 270(1):111-23. PubMed ID: 10772984
[TBL] [Abstract][Full Text] [Related]
3. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE
Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
Kinney RM; Chang GJ; Tsuchiya KR; Sneider JM; Roehrig JT; Woodward TM; Trent DW
J Virol; 1993 Mar; 67(3):1269-77. PubMed ID: 7679745
[TBL] [Abstract][Full Text] [Related]
5. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone.
Davis NL; Powell N; Greenwald GF; Willis LV; Johnson BJ; Smith JF; Johnston RE
Virology; 1991 Jul; 183(1):20-31. PubMed ID: 2053280
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
[TBL] [Abstract][Full Text] [Related]
7. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.
Davis NL; Brown KW; Greenwald GF; Zajac AJ; Zacny VL; Smith JF; Johnston RE
Virology; 1995 Sep; 212(1):102-10. PubMed ID: 7676619
[TBL] [Abstract][Full Text] [Related]
8. Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.
Turell MJ; Ludwig GV; Kondig J; Smith JF
Am J Trop Med Hyg; 1999 Jun; 60(6):1041-4. PubMed ID: 10403340
[TBL] [Abstract][Full Text] [Related]
9. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
[TBL] [Abstract][Full Text] [Related]
10. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus.
Bennett AM; Lescott T; Phillpotts RJ
Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402
[TBL] [Abstract][Full Text] [Related]
11. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models.
Pratt WD; Davis NL; Johnston RE; Smith JF
Vaccine; 2003 Sep; 21(25-26):3854-62. PubMed ID: 12922119
[TBL] [Abstract][Full Text] [Related]
12. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.
MacDonald GH; Johnston RE
J Virol; 2000 Jan; 74(2):914-22. PubMed ID: 10623754
[TBL] [Abstract][Full Text] [Related]
13. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
[TBL] [Abstract][Full Text] [Related]
14. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
[TBL] [Abstract][Full Text] [Related]
15. Glycoproteins E2 of the Venezuelan and eastern equine encephalomyelitis viruses contain multiple cross-reactive epitopes.
Pereboev AV; Razumov IA; Svyatchenko VA; Loktev VB
Arch Virol; 1996; 141(11):2191-205. PubMed ID: 8973533
[TBL] [Abstract][Full Text] [Related]
16. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.
White LJ; Wang JG; Davis NL; Johnston RE
J Virol; 2001 Apr; 75(8):3706-18. PubMed ID: 11264360
[TBL] [Abstract][Full Text] [Related]
17. Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein.
Brault AC; Powers AM; Ortiz D; Estrada-Franco JG; Navarro-Lopez R; Weaver SC
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11344-9. PubMed ID: 15277679
[TBL] [Abstract][Full Text] [Related]
18. Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus.
Brault AC; Powers AM; Holmes EC; Woelk CH; Weaver SC
J Virol; 2002 Feb; 76(4):1718-30. PubMed ID: 11799167
[TBL] [Abstract][Full Text] [Related]
19. Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein.
Johnson BJ; Brubaker JR; Roehrig JT; Trent DW
Virology; 1990 Aug; 177(2):676-83. PubMed ID: 1695412
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
